• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AQP2:与先天性肾性尿崩症相关的突变及翻译后修饰和蛋白-蛋白相互作用的调节。

AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.

机构信息

Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA.

出版信息

Cells. 2020 Sep 26;9(10):2172. doi: 10.3390/cells9102172.

DOI:10.3390/cells9102172
PMID:32993088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7599609/
Abstract

As a rare hereditary disease, congenital nephrogenic diabetes insipidus (NDI) is clinically characterized by polyuria with hyposthenuria and polydipsia. NDI results from collecting duct principal cell hyporesponsiveness or insensitivity to the antidiuretic action of arginine vasopressin (AVP). The principal cell-specific water channel aquaporin-2 (AQP2) plays an essential role in water reabsorption along osmotic gradients. The capacity to accumulate AQP2 in the apical plasma membrane in response to decreased fluid volume or increased plasma osmolality is critically regulated by the antidiuretic hormone AVP and its receptor 2 (AVPR2). Mutations in result in X-linked recessive NDI, the most common form of inherited NDI. Genetic defects in cause autosomal recessive or dominant NDI. In this review, we provide an updated overview of the genetic and molecular mechanisms of congenital NDI, with a focus on the potential disease-causing mutations in and , the molecular defects in the AVPR2 and AQP2 mutants, post-translational modifications (i.e., phosphorylation, ubiquitination, and glycosylation) and various protein-protein interactions that regulate phosphorylation, ubiquitination, tetramerization, trafficking, stability, and degradation of AQP2.

摘要

作为一种罕见的遗传性疾病,先天性肾性尿崩症(NDI)的临床特征为多尿伴尿比重降低和多饮。NDI 是由于集合管主细胞对血管加压素(AVP)的抗利尿作用反应迟钝或不敏感所致。主细胞特异性水通道 aquaporin-2(AQP2)在渗透压梯度下的水重吸收中起着至关重要的作用。AQP2 在细胞顶部质膜中的积累能力受抗利尿激素 AVP 和其受体 2(AVPR2)的严格调节。 中的突变导致 X 连锁隐性 NDI,这是最常见的遗传性 NDI 形式。 中的遗传缺陷导致常染色体隐性或显性 NDI。在这篇综述中,我们提供了先天性 NDI 的遗传和分子机制的最新概述,重点介绍了 和 中的潜在致病突变、AVPR2 和 AQP2 突变体的分子缺陷、翻译后修饰(即磷酸化、泛素化和糖基化)以及各种调节 AQP2 的磷酸化、泛素化、四聚体化、运输、稳定性和降解的蛋白-蛋白相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/7599609/412840a94eb9/cells-09-02172-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/7599609/34a00b168dbd/cells-09-02172-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/7599609/412840a94eb9/cells-09-02172-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/7599609/34a00b168dbd/cells-09-02172-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458f/7599609/412840a94eb9/cells-09-02172-g002.jpg

相似文献

1
AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.AQP2:与先天性肾性尿崩症相关的突变及翻译后修饰和蛋白-蛋白相互作用的调节。
Cells. 2020 Sep 26;9(10):2172. doi: 10.3390/cells9102172.
2
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.遗传性肾性尿崩症:病理生理学和可能的治疗。更新。
Int J Mol Sci. 2017 Nov 10;18(11):2385. doi: 10.3390/ijms18112385.
3
Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).肾性尿崩症(NDI)的遗传形式:血管加压素受体缺陷(X连锁)和水通道蛋白缺陷(常染色体隐性和显性)。
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):263-76. doi: 10.1016/j.beem.2016.02.010. Epub 2016 Mar 2.
4
A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.家族性中枢性尿崩症伴 X 连锁遗传性肾性尿崩症女性:病例报告及文献复习。
Am J Med Genet A. 2020 May;182(5):1032-1040. doi: 10.1002/ajmg.a.61516. Epub 2020 Feb 19.
5
V2R mutations and nephrogenic diabetes insipidus.V2R 突变与肾性尿崩症。
Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7.
6
Nephrogenic diabetes insipidus.肾性尿崩症
Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006.
7
Physiopathology and diagnosis of nephrogenic diabetes insipidus.肾源性尿崩症的病理生理学和诊断。
Ann Endocrinol (Paris). 2012 Apr;73(2):128-9. doi: 10.1016/j.ando.2012.03.032. Epub 2012 Apr 13.
8
[Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].[由水通道蛋白2(AQP2)中新的纯合突变p.R113C引起的精氨酸加压素抵抗的临床和实验室特征]
Probl Endokrinol (Mosk). 2023 May 12;69(2):75-79. doi: 10.14341/probl13188.
9
Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.日本遗传性肾性尿崩症患者:AVPR2 和 AQP2 中 78 个家系的分析及 22 个新突变的报告。
Clin Exp Nephrol. 2013 Jun;17(3):338-44. doi: 10.1007/s10157-012-0726-z. Epub 2012 Nov 14.
10
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.肾源性尿崩症:对分子背景的基本认识及治疗的潜在疗法。
Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29.

引用本文的文献

1
Case Report of Nephrogenic Diabetes Insipidus with a Novel Mutation in the Gene.一例伴有该基因新突变的肾性尿崩症病例报告。
Int J Mol Sci. 2025 Aug 1;26(15):7415. doi: 10.3390/ijms26157415.
2
Distinctive roles of aquaporins and novel therapeutic opportunities against cancer.水通道蛋白的独特作用及抗癌新治疗机遇
RSC Med Chem. 2024 Dec 17. doi: 10.1039/d4md00786g.
3
Exosomes on the development and progression of renal fibrosis.外泌体在肾纤维化发生发展中的作用。

本文引用的文献

1
GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus.内分泌遗传学 家族性肾性尿崩症的病理生理学、诊断和治疗。
Eur J Endocrinol. 2020 Aug;183(2):R29-R40. doi: 10.1530/EJE-20-0114.
2
Sorting Nexin 27 Regulates the Lysosomal Degradation of Aquaporin-2 Protein in the Kidney Collecting Duct.分选连接蛋白 27 调控肾脏集合管水通道蛋白-2 蛋白的溶酶体降解
Cells. 2020 May 13;9(5):1208. doi: 10.3390/cells9051208.
3
PKA-independent vasopressin signaling in renal collecting duct.肾集合管中与蛋白激酶 A 无关的血管加压素信号转导
Cell Prolif. 2024 Nov;57(11):e13677. doi: 10.1111/cpr.13677. Epub 2024 Jun 19.
4
A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.一例先天性肾性尿崩症伴水通道蛋白 2 基因突变及随后发生急性淋巴细胞白血病:激素对肾功能的影响。
Am J Case Rep. 2024 May 21;25:e943597. doi: 10.12659/AJCR.943597.
5
Sequence and structural insights of monoleucine-based sorting motifs contained within the cytoplasmic domains of basolateral proteins.位于基底外侧蛋白胞质结构域内的基于单亮氨酸的分选基序的序列和结构见解。
Front Cell Dev Biol. 2024 Mar 1;12:1379224. doi: 10.3389/fcell.2024.1379224. eCollection 2024.
6
Structural and functional analysis of aquaporin-2 mutants involved in nephrogenic diabetes insipidus.水通道蛋白-2 突变体在肾性尿崩症中的结构与功能分析。
Sci Rep. 2023 Sep 6;13(1):14674. doi: 10.1038/s41598-023-41616-1.
7
Differentiated mouse kidney tubuloids as a novel model to study collecting duct physiology.分化的小鼠肾小管类器官作为研究集合管生理学的新型模型。
Front Cell Dev Biol. 2023 Jan 25;11:1086823. doi: 10.3389/fcell.2023.1086823. eCollection 2023.
8
Congenital nephrogenic diabetes insipidus arginine vasopressin receptor 2 gene mutation at new site: A case report.先天性肾性尿崩症精氨酸加压素受体2基因新位点突变:一例报告
World J Clin Cases. 2022 Dec 26;10(36):13443-13450. doi: 10.12998/wjcc.v10.i36.13443.
9
Advances in Aquaporins.水通道蛋白的研究进展。
Cells. 2023 Jan 13;12(2):303. doi: 10.3390/cells12020303.
10
Exploration of the cancer genome atlas database reveals genes of interest related with cancer cell stemness indices in clear cell renal cell carcinoma.对癌症基因组图谱数据库的探索揭示了与透明细胞肾细胞癌中癌细胞干性指数相关的感兴趣基因。
Heliyon. 2022 Nov 23;8(12):e11794. doi: 10.1016/j.heliyon.2022.e11794. eCollection 2022 Dec.
FASEB J. 2020 May;34(5):6129-6146. doi: 10.1096/fj.201902982R. Epub 2020 Mar 26.
4
Rab7 involves Vps35 to mediate AQP2 sorting and apical trafficking in collecting duct cells.Rab7 通过与 Vps35 相互作用来介导水通道蛋白 2 的分拣和顶端转运过程。
Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F956-F970. doi: 10.1152/ajprenal.00297.2019. Epub 2020 Feb 24.
5
Aquaporins in the kidney: physiology and pathophysiology.水通道蛋白在肾脏中的作用:生理学和病理生理学。
Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F193-F203. doi: 10.1152/ajprenal.00304.2019. Epub 2019 Nov 4.
6
Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.靶向肾脏水通道的转运以获得治疗益处。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:175-194. doi: 10.1146/annurev-pharmtox-010919-023654. Epub 2019 Sep 27.
7
The Deubiquitylase USP4 Interacts with the Water Channel AQP2 to Modulate Its Apical Membrane Accumulation and Cellular Abundance.去泛素化酶 USP4 与水通道蛋白 AQP2 相互作用,调节其顶端膜积累和细胞丰度。
Cells. 2019 Mar 21;8(3):265. doi: 10.3390/cells8030265.
8
Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.胆酸 G 蛋白偶联膜受体 TGR5 调节水通道蛋白 2 介导的水稳态。
J Am Soc Nephrol. 2018 Nov;29(11):2658-2670. doi: 10.1681/ASN.2018030271. Epub 2018 Oct 10.
9
AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.AKAPs-PKA 抑制剂可在肾性尿崩症模型中独立于血管加压素增加 AQP2 的活性。
Nat Commun. 2018 Apr 12;9(1):1411. doi: 10.1038/s41467-018-03771-2.
10
Identification of UT-A1- and AQP2-interacting proteins in rat inner medullary collecting duct.鉴定大鼠内髓集合管中 UT-A1 和 AQP2 的相互作用蛋白。
Am J Physiol Cell Physiol. 2018 Jan 1;314(1):C99-C117. doi: 10.1152/ajpcell.00082.2017. Epub 2017 Oct 18.